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SUMMARY – Th e Department of Urology at the Sestre milosrdnice University Hospital Center 
is the oldest urological institution in the Republic of Croatia and this part of Europe. Today, the De-
partment is a modern tertiary healthcare institution, where the most complex methods of urological 
practice are performed using modern medical devices and highly sophisticated technology. In 2011, 
our urology specialist education program was certifi ed by the European Board of Urology (EBU) as 
the only one of its kind in Croatia. Th e program was recertifi ed in 2017. Th e Department runs a pro-
gram for the early detection of prostate cancer and performs more than 240 radical prostatectomies 
annually, which is the highest number of such interventions in Croatia. Th e aim of this study is to 
present the work and the activities of the Reference Center for Prostate Tumors of the Ministry of 
Health at the Department of Urology in Sestre milosrdnice University Hospital Center over the last 
20 years. Th e database of the Reference Center for Prostate Tumors of the Ministry of Health at the 
Department of Urology in Sestre milosrdnice University Hospital Center was reviewed. During the 
twenty-year period, approximately 15,000 prostate interventions were performed due to benign and 
malignant diseases. Of this, 7,374 transrectal ultrasound guided prostate biopsies, 2,632 radical pros-
tatectomies with open retropubic access, 3,988 transurethral prostate resections and 1,097 open supra-
pubic adenomectomies were performed. With the achieved scientifi c and professional results in mon-
itoring, studying and improving the prevention, diagnosis and therapy of prostate tumors, as well as 
with the professional conditions and personnel, the Department of Urology in Sestre milosrdnice 
University Hospital Center truly justifi es the title of the Reference Center for Prostate Tumors of the 
Ministry of Health of the Republic of Croatia awarded to it in 1998.
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Introduction
Th e Department of Urology in Sestre milosrdnice 
University Hospital Center is the oldest urological in-
stitution in the Republic of Croatia and this part of 
Europe. Th e fi rst independent urology department was 
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founded in 1928 and in 1943 it was awarded the status 
of a university department, the fi rst one in Croatia.
Today, the Department of Urology in Sestre mi-
losrdnice University Hospital Center is a modern ter-
tiary healthcare institution where the most complex 
methods of urological practice are performed using 
modern medical devices and highly sophisticated 
technology. Our Department provides education to 
young doctors from all over Croatia, from undergradu-
ate classes to specialist and subspecialist training in 
urology.
A reference center of the Ministry of Health is a 
health institution to which the Minister of Health 
awards the title of the Reference Center at the pro-
posal of the National Health Council, with the opin-
ion of the professional medical society, and in accor-
dance with the provisions of the Health Care Act and 
the criteria defi ned by the Ordinance on the criteria 
for the award of the title of a reference center.
Th e Department of Urology in Sestre milosrdnice 
University Hospital Center has been the Reference 
Center for Prostate Tumors of the Ministry of Health 
since 1998. In the last 20 years, the Department staff  
have been trying to justify this name through surgical 
and scientifi c work. Over the years, experience has 
been gained, surgical techniques have been altered and 
the Department has even become an education center 
where urology practitioners across the country learn 
the skills of prostate tumor treatment. In 2011, our 
urology specialist education program was certifi ed by 
the European Board of Urology (EBU) as the only one 
in the Republic of Croatia, Th e program was recerti-
fi ed in 2017. Th e Department runs a program of early 
detection of prostate cancer and performs more than 
240 radical prostatectomies annually, which is the 
highest number of such interventions in Croatia.
Aim
Th e aim of this study was to present the work and 
the activities of the Reference Center for Prostate Tu-
mors of the Ministry of Health at the Department of 
Urology in Sestre milosrdnice University Hospital 
Center over the last 20 years.
Methods
A review of the database of the Reference Center 
for Prostate Tumors of the Ministry of Health at the 
Department of Urology in Sestre milosrdnice Univer-
sity Hospital Center was performed. Data from the 
medical history, operational protocols and histopatho-
logical fi ndings were analyzed. Th e results are ex-
pressed in mean ± standard deviation by period, and 
the diff erence in trends compared with the nonpara-
metric t-test at the level of signifi cance p <0.05.
Results
During the twenty-year period from 1 January 
1998 to 31 December 2017, approximately 15,000 
prostate interventions were performed due to benign 
and malignant diseases (Table 1). Of this, 7,374 tran-
srectal ultrasound guided prostate biopsies, 2,632 radi-
cal prostatectomies with open retropubic access, 3,988 
transurethral prostate resections and 1,097 open su-
prapubic adenomectomies were performed. Changes 
in the treatment of benign enlargement of the prostate 
by introducing pharmacological therapy resulted in 
the reduction of surgical treatment of this condition 
(Fig. 1).
Table 1. Total number of prostate procedures over the last 
20 years






Th e number of benign prostatic hyperplasia surger-
ies decreased from 314.30 ± 64.48 to 194.20 ± 46.97 
(p = 0.0002, 95% CI 67.10 - 173.10) in the period 
1998-2008 and 2008-2017, respectively. Th e compari-
son of the number of radical prostatectomies per-
formed during the fi rst 10 years of the Reference Cen-
ter for Prostate Tumors (mean 71.60 ± 54.36, range 
4-136) with the subsequent 10 years (191.60 ± 23.74, 
range 157-247) provides an insight into an increasing 
trend of the surgical treatment of prostate cancer (p 
<0.001, 95% CI -159.41 to -80.59). In the observed 
periods, the number of biopsy procedures increased 
from 262.3 ± 154.1 to 475.1 ± 74.44 (p <0.001, 95% 
CI -326.50 to -99.10) (Fig. 2). We managed to de-
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crease the proportion of insignifi cant prostate cancer 
among patients who had undergone radical prostatec-
tomy in the studied period with the introduction of 
active surveillance for prostate cancer (Fig. 3.). In ad-
dition to analyzing the change in treatment trends in 
the Reference Center, the validation of results and the 
quality of treatment is compared to other centers of 
excellence, as evidenced by the extensive published 
material that accompanies the work of the Reference 
Center. It is of note that over the years the topics of 
scientifi c articles have been changing. Th roughout the 
whole period, benign prostatic conditions remained of 
interest both regarding treatment options and study-
ing practice patterns1-4. Nevertheless, most of our pub-
lications relate to prostate cancer. Some of the studies 
discussed biopsy issues5-8, while others discussed prog-
nostic parameters and treatment options9-29. Over the 
last years, authors focused on the  importance of insig-
nifi cant cancers and active surveillance as an emerging 
approach to treating patients with this diagnosis30,31. 
Global infl uence of  prostate specifi c antigen use on 
mortality was also analyzed32.
Fig. 1. Number of TURP and transvesical adenomectomies over the last 20 years.
Fig. 2. Number of radical prostatectomies 1998-2017.
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Conclusion
With the achieved scientifi c and professional re-
sults in monitoring, studying and improving preven-
tion, diagnosis and therapy of prostate tumors, as well 
as professional and personnel conditions, the Depart-
ment of Urology in Sestre milosrdnice University 
Hospital Center truly justifi es the title of the Refer-
ence Center for Prostate Tumors of the Ministry of 
Health awarded to it in 1998.
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Sažetak
20 GODINA REFERENTNOG CENTRA ZA TUMORE PROSTATE MINISTARSTVA ZDRAVSTVA 
U KLINICI ZA UROLOGIJU KBC SESTRE MILOSRDNICE
I. Tomašković, S. Nikles, I. Pezelj, M. Tomić, I. Svaguša, M. Pirša, D. Justinić, I. Grubišić, M. Knežević, 
B. Vrhovec, A. Popović, G. Štimac, A. Reljić, B. Spajić i B. Ružić
Klinika za urologiju Kliničkog bolničkog centra Sestre milosrdnice najstarija je urološka ustanova u Republici Hrvatskoj, 
a i u ovom dijelu Europe. Danas je Klinika za urologiju moderna medicinska ustanova tercijarne zdravstvene zaštite gdje se 
najsloženije metode urološke prakse izvode pomoću suvremenih medicinskih uređaja i visoko sofi sticirane tehnologije. 
 Program edukacije specijalizanata je 2011. godine certifi ciran od strane European Board of Urology (EBU) kao jedini takav 
u Hrvatskoj, a recertifi ciran je 2017. godine. U našoj se Klinici provodi program ranog otkrivanja raka prostate, a godišnje se 
obavlja preko 240 radikalnih prostatektomija što je ujedno i najveći broj takvih zahvata u Hrvatskoj. Cilj rada je prikazati rad 
i aktivnost Referentnog centra Ministarstva zdravstva za tumore prostate u Klinici za urologiju KBC „Sestre milosrdnice“ u 
posljednjih 20 godina. Učinjen je pregled baze podataka Referentnog centra za tumore prostate Ministarstva zdravstva u 
Klinici za urologiju KBC „Sestre milosrdnice“. Tijekom dvadesetogodišnjeg razdoblja učinjeno je oko 15 000 zahvata na 
prostati zbog benignih i malignih bolesti. Od toga je učinjena 7 374 biopsija prostate vođene transrektalnim ultrazvukom, 2 
632 radikalnih prostatekomija otvorenim retropubičnim pristupom, 3 988 transuretralnih resekcija prostate i 1 097 otvorenih 
suprapubičnih adenomektomija. Postignutim znanstvenim i stručnim rezultatima u praćenju, proučavanju i unaprjeđenju 
prevencije, dijagnostike i terapije tumora prostate kao i stručno-kadrovskim uvjetima, Klinika za urologiju KBC Sestre 
 milosrdnice opravdava naslov Referentnog centra za tumore prostate Ministarstva zdravstva Republike Hrvatske koji nosi od 
1998. godine.
Ključne riječi: Prostata; Karcinom prostate; Klinika za urologiju; Referentni centar za tumore prostate; European Board of 
 Urology (EBU)
